임신 중 lithium hydroxide을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

lithium hydroxide은 임신 중 안전한가요?

ECHA/RAC has proposed harmonised classification for lithium hydroxide as reproductive toxicant (Repr. 1A, H360—may damage fertility/unborn child) and lactation (H362); regulatory bodies and risk assessments driving that proposal cite mammalian data and human lithium drug literature showing placental transfer and developmental effects. This supports a confirmed hazard (H360 → h=3) and a demonstrated mechanism (placental transfer / developmental signalling effects from lithium). Topical cosmetic exposure would give low but measurable systemic exposure in normal use (hence e=1). (Sources: ECHA registry and RAC/ANSES material; PubMed reviews on lithium exposure in pregnancy).

lithium hydroxide은 모유 수유 중 안전한가요?

RAC/ANSES proposals include a lactation hazard (H362) for lithium salts; clinical/literature on therapeutic lithium shows transfer into breastmilk and effects on breastfed infants, supporting a confirmed hazard (h=3) and demonstrated mechanism (maternal→milk transfer). Topical cosmetic use is expected to give low but measurable maternal systemic exposure (e=1) unless formulations/uses provide negligible absorption. (Sources: ECHA/ANSES/RAC documentation; PubMed clinical reviews on lithium and breastfeeding).

lithium hydroxide은 아기 피부에 안전한가요?

Hazard and mechanism remain driven by the same lithium salt evidence (RAC proposal Repr.1A/H360 and lactation H362; systemic lithium crosses placenta and is secreted in milk). Because infant skin (0–3 yr) has higher surface-area-to-weight and a less mature barrier, exposure score is increased by +1 (adult e=1 → infant e=2). There is no infant-specific evidence changing hazard or mechanism, but increased dermal exposure potential supports higher exposure concern for babies. (Sources: ECHA/ANSES/RAC; PubMed literature on lithium transfer and infant effects; CosIng listing and restriction notes).

VeriMom은 lithium hydroxide을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 lithium hydroxide을 20/100 (높은 위험)로 평가합니다.

임신 중 lithium hydroxide 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.